The medication intelligence company Bluesight will host a virtual symposium that addresses challenges related to drug diversion on March 22, from 12 p.m. to 3 p.m. Eastern time.
The event will include three webinars moderated by Sandy Still, PharmD, Bluesight’s director of clinical strategy. The sessions will focus on issues in drug diversion prevention, such as deciding which stakeholders to include in a diversion prevention committee, practice issues to address and how to build a
MARCH 1, 2023